85 related articles for article (PubMed ID: 25435408)
1. Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride.
Kalia V; Garg T; Rath G; Goyal AK
Artif Cells Nanomed Biotechnol; 2016 May; 44(3):842-6. PubMed ID: 25435408
[TBL] [Abstract][Full Text] [Related]
2. Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance.
Ahmed S; El-Setouhy DA; El-Latif Badawi AA; El-Nabarawi MA
Eur J Pharm Sci; 2014 Aug; 60():10-23. PubMed ID: 24793896
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of dual action intranasal formulation intended for postoperative/cancer associated therapies.
El-Setouhy DA; Ahmed S; Badawi AA; El-Nabarawi MA; Sallam N
Eur J Pharm Sci; 2015 Aug; 76():48-56. PubMed ID: 25917526
[TBL] [Abstract][Full Text] [Related]
4. Development of Nasal Mucoadhesive Microspheres of Granisetron: A Potential Drug.
Pandey J; Shankar R; Kumar M; Shukla K; Kumari B
Drug Res (Stuttg); 2020 Aug; 70(8):367. PubMed ID: 32559774
[TBL] [Abstract][Full Text] [Related]
5. In vitro percutaneous absorption enhancement of granisetron by chemical penetration enhancers.
Zhao N; Cun D; Li W; Ma X; Sun L; Xi H; Li L; Fang L
Drug Dev Ind Pharm; 2013 Apr; 39(4):561-8. PubMed ID: 22424279
[TBL] [Abstract][Full Text] [Related]
6. Dermal, subdermal, and systemic concentrations of granisetron by iontophoretic delivery.
Chaturvedula A; Joshi DP; Anderson C; Morris R; Sembrowich WL; Banga AK
Pharm Res; 2005 Aug; 22(8):1313-9. PubMed ID: 16078141
[TBL] [Abstract][Full Text] [Related]
7. A pharmacologic profile of oral granisetron (Kytril tablets).
Blower P
Semin Oncol; 1995 Aug; 22(4 Suppl 10):3-5. PubMed ID: 7570052
[No Abstract] [Full Text] [Related]
8. Synthesis, Characterization and Biocompatibility of N-palmitoyl L-alanine-based Organogels as Sustained Implants of Granisetron and Evaluation of thier Antiemetic Effect.
El-Nassan HB; ElMeshad AN; Wadie W; Sayed RH
Pharm Res; 2018 May; 35(8):149. PubMed ID: 29845459
[TBL] [Abstract][Full Text] [Related]
9. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy.
Endo J; Iihara H; Yamada M; Yanase K; Kamiya F; Ito F; Funaguchi N; Ohno Y; Minatoguchi S; Itoh Y
Anticancer Res; 2012 Sep; 32(9):3939-47. PubMed ID: 22993341
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of granisetron hydrochloride for nausea and vomiting induced by oral anticancer drugs].
Togo S; Kunisaki C; Moriwaki Y; Yamaguchi S; Ichikawa Y; Oki S; Shimada H; Takahashi M; Ike H; Fukushima T; Obi Y; Kubo A; Takahashi T; Hosoi H; Fukazawa S; Suda T; Yamazaki Y
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1021-8. PubMed ID: 10925688
[TBL] [Abstract][Full Text] [Related]
12. Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance.
Sharma R; Kamboj S; Singh G; Rana V
Eur J Pharm Sci; 2016 Mar; 84():55-69. PubMed ID: 26780381
[TBL] [Abstract][Full Text] [Related]
13. Transmucosal delivery of metformin- a comprehensive study.
Sushma M; Raju YP; Sundaresan CR; Vandana KR; Kumar NV; Chowdary VH
Curr Drug Deliv; 2014; 11(2):172-8. PubMed ID: 23848354
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Optimization of Fast Dissolving Film of Naratr iptan Hydrochloride.
Krishna KD; Pradip ST; Navin SR
Recent Pat Drug Deliv Formul; 2017; 11(2):124-131. PubMed ID: 28201962
[TBL] [Abstract][Full Text] [Related]
15. Granisetron, an antiemetic drug, and its cobalt complex.
Ravikumar K; Sridhar B
Acta Crystallogr C; 2010 Feb; 66(Pt 2):m35-9. PubMed ID: 20124677
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive polymers-based film as a carrier system for sublingual delivery of glutathione.
Chen G; Bunt C; Wen J
J Pharm Pharmacol; 2015 Jan; 67(1):26-34. PubMed ID: 25303221
[TBL] [Abstract][Full Text] [Related]
17. Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy.
Gurpide A; Sadaba B; Martin-Algarra S; Azanza JR; Lopez-Picazo JM; Campanero MA; Cabello JP; Gil-Aldea I; de la Cruz S; Fernandez Gallego V; Reyna C; Olier Garate C; Blanco-Prieto MJ; Ceballos J; Garcia-Foncillas J; Perez-Gracia JL
Oncologist; 2007 Sep; 12(9):1151-5. PubMed ID: 17914085
[TBL] [Abstract][Full Text] [Related]
18. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis.
Park DM; Song YK; Jee JP; Kim HT; Kim CK
Drug Dev Ind Pharm; 2012 Sep; 38(9):1077-83. PubMed ID: 22182584
[TBL] [Abstract][Full Text] [Related]
19. Thermal and non-thermal methods to evaluate compatibility of granisetron hydrochloride with tablet excipients.
Late SG; Banga AK
Pharmazie; 2008 Jun; 63(6):453-8. PubMed ID: 18604989
[TBL] [Abstract][Full Text] [Related]
20. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
